Activity enhancement of a lung cancer–associated human monoclonal antibody HB4C5 by N-deglycosylation

Masatoshi Kato, Katsumi Mochizuki, Shuichi Hashizume, Hirofumi Tachibana, Sanetaka Shirahata, Hiroki Murakami

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

It has been known that the lung cancer–associated human monoclonal antibody HB4C5 comprises two lambda light chains of 30 and 32 kD and that the 30 kD species is exclusively responsible for the antibody activity. This study demonstrates that the two light chains were both N-glycosylated with glycosyl residues of different sizes, one of which was sensitive to neuraminidase and the other insensitive. Our unpublished data of DNA sequence for the light chain of this monoclonal antibody indicated that the light chain contains only one possible site for N-glycosylation, which located in the CDR-1. N-Deglycosylation of this monoclonal antibody under the denaturing condition resulted in the complete conversion of the two light chains into one identical polypeptide chain of 26 kD. Activity of this monoclonal antibody was found to be significantly enhanced by N-deglycosylation. All the facts described above consistently indicate that the activity of this monoclonal antibody is interfered with by the attachment of bulky glycosyl residues at the antigen binding site on the light chain. The N-deglycosylated antibody was stable under the storage conditions employed, suggesting that the glycosyl residues attached to the light chain do not play any important biological role except for interference with the antibody activity of binding antigen.

Original languageEnglish
Pages (from-to)9-14
Number of pages6
JournalHuman Antibodies
Volume4
Issue number1
DOIs
Publication statusPublished - Jan 1 1993

Fingerprint

Monoclonal Antibodies
Light
Lung
Antibodies
Antigens
Neuraminidase
Glycosylation
Binding Sites
Peptides

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

Cite this

Activity enhancement of a lung cancer–associated human monoclonal antibody HB4C5 by N-deglycosylation. / Kato, Masatoshi; Mochizuki, Katsumi; Hashizume, Shuichi; Tachibana, Hirofumi; Shirahata, Sanetaka; Murakami, Hiroki.

In: Human Antibodies, Vol. 4, No. 1, 01.01.1993, p. 9-14.

Research output: Contribution to journalArticle

Kato, Masatoshi ; Mochizuki, Katsumi ; Hashizume, Shuichi ; Tachibana, Hirofumi ; Shirahata, Sanetaka ; Murakami, Hiroki. / Activity enhancement of a lung cancer–associated human monoclonal antibody HB4C5 by N-deglycosylation. In: Human Antibodies. 1993 ; Vol. 4, No. 1. pp. 9-14.
@article{dc267058dd8e463799db89ff2fe38a59,
title = "Activity enhancement of a lung cancer–associated human monoclonal antibody HB4C5 by N-deglycosylation",
abstract = "It has been known that the lung cancer–associated human monoclonal antibody HB4C5 comprises two lambda light chains of 30 and 32 kD and that the 30 kD species is exclusively responsible for the antibody activity. This study demonstrates that the two light chains were both N-glycosylated with glycosyl residues of different sizes, one of which was sensitive to neuraminidase and the other insensitive. Our unpublished data of DNA sequence for the light chain of this monoclonal antibody indicated that the light chain contains only one possible site for N-glycosylation, which located in the CDR-1. N-Deglycosylation of this monoclonal antibody under the denaturing condition resulted in the complete conversion of the two light chains into one identical polypeptide chain of 26 kD. Activity of this monoclonal antibody was found to be significantly enhanced by N-deglycosylation. All the facts described above consistently indicate that the activity of this monoclonal antibody is interfered with by the attachment of bulky glycosyl residues at the antigen binding site on the light chain. The N-deglycosylated antibody was stable under the storage conditions employed, suggesting that the glycosyl residues attached to the light chain do not play any important biological role except for interference with the antibody activity of binding antigen.",
author = "Masatoshi Kato and Katsumi Mochizuki and Shuichi Hashizume and Hirofumi Tachibana and Sanetaka Shirahata and Hiroki Murakami",
year = "1993",
month = "1",
day = "1",
doi = "10.3233/HAB-1993-4102",
language = "English",
volume = "4",
pages = "9--14",
journal = "Human Antibodies",
issn = "1093-2607",
publisher = "IOS Press",
number = "1",

}

TY - JOUR

T1 - Activity enhancement of a lung cancer–associated human monoclonal antibody HB4C5 by N-deglycosylation

AU - Kato, Masatoshi

AU - Mochizuki, Katsumi

AU - Hashizume, Shuichi

AU - Tachibana, Hirofumi

AU - Shirahata, Sanetaka

AU - Murakami, Hiroki

PY - 1993/1/1

Y1 - 1993/1/1

N2 - It has been known that the lung cancer–associated human monoclonal antibody HB4C5 comprises two lambda light chains of 30 and 32 kD and that the 30 kD species is exclusively responsible for the antibody activity. This study demonstrates that the two light chains were both N-glycosylated with glycosyl residues of different sizes, one of which was sensitive to neuraminidase and the other insensitive. Our unpublished data of DNA sequence for the light chain of this monoclonal antibody indicated that the light chain contains only one possible site for N-glycosylation, which located in the CDR-1. N-Deglycosylation of this monoclonal antibody under the denaturing condition resulted in the complete conversion of the two light chains into one identical polypeptide chain of 26 kD. Activity of this monoclonal antibody was found to be significantly enhanced by N-deglycosylation. All the facts described above consistently indicate that the activity of this monoclonal antibody is interfered with by the attachment of bulky glycosyl residues at the antigen binding site on the light chain. The N-deglycosylated antibody was stable under the storage conditions employed, suggesting that the glycosyl residues attached to the light chain do not play any important biological role except for interference with the antibody activity of binding antigen.

AB - It has been known that the lung cancer–associated human monoclonal antibody HB4C5 comprises two lambda light chains of 30 and 32 kD and that the 30 kD species is exclusively responsible for the antibody activity. This study demonstrates that the two light chains were both N-glycosylated with glycosyl residues of different sizes, one of which was sensitive to neuraminidase and the other insensitive. Our unpublished data of DNA sequence for the light chain of this monoclonal antibody indicated that the light chain contains only one possible site for N-glycosylation, which located in the CDR-1. N-Deglycosylation of this monoclonal antibody under the denaturing condition resulted in the complete conversion of the two light chains into one identical polypeptide chain of 26 kD. Activity of this monoclonal antibody was found to be significantly enhanced by N-deglycosylation. All the facts described above consistently indicate that the activity of this monoclonal antibody is interfered with by the attachment of bulky glycosyl residues at the antigen binding site on the light chain. The N-deglycosylated antibody was stable under the storage conditions employed, suggesting that the glycosyl residues attached to the light chain do not play any important biological role except for interference with the antibody activity of binding antigen.

UR - http://www.scopus.com/inward/record.url?scp=0027518486&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027518486&partnerID=8YFLogxK

U2 - 10.3233/HAB-1993-4102

DO - 10.3233/HAB-1993-4102

M3 - Article

VL - 4

SP - 9

EP - 14

JO - Human Antibodies

JF - Human Antibodies

SN - 1093-2607

IS - 1

ER -